Related by context. All words. (Click for frequent words.) 67 oral prodrug 66 hepatitis C HCV 66 naive HCV 65 post herpetic neuralgia PHN 65 Hepatitis C HCV 65 CEQ# 65 nucleotide analog 64 HGS ETR1 mapatumumab 64 refractory gout 64 hepatitis C virus HCV 64 chronic HCV 64 hepatitis B virus HBV 64 Familial Adenomatous Polyposis FAP 64 CCR5 tropic HIV 64 forodesine 64 Staphylococcus aureus infections 64 hepatitis B HBV 64 Omacetaxine 63 AEG# 63 dasatinib Sprycel ® 63 Epstein Barr virus EBV 63 lucinactant 63 Tamibarotene 63 varicella zoster virus VZV 63 PEGylated Fab fragment 63 virus HCV infection 63 ALN TTR 63 Aganocide 63 Bezielle 63 hyperphenylalaninemia HPA due 63 evaluating tivozanib 63 Lupus nephritis 63 either acutely decompensated 62 LymphoStat B belimumab 62 chemotherapy induced neutropenia 62 NS#/#A protease 62 arthritis PsA 62 recurrent genital herpes 62 Ribavirin causes 62 HCV genotypes 62 Ganciclovir 62 Amgen Neulasta R 62 PNP inhibitor 62 replicon 62 MyVax ® 62 CMV infection 62 Cethromycin 62 CYT# potent vascular disrupting 62 TYZEKA 62 diarrhea predominant irritable 62 Ebola virus infection 62 gastrointestinal stromal tumors GIST 62 CCR5 mAb 62 S. aureus infections 62 genotype 1b 62 MVA BN R 62 Escherichia coli Klebsiella pneumoniae 62 chronic HCV infection 62 Recombinant interferon alpha 62 chronic HCV genotype 62 investigational humanized monoclonal antibody 62 Alferon N 62 cytomegalovirus CMV 62 naive HCV genotype 62 daptomycin 62 chronic HBV infection 62 treatment naive genotype 62 enterotoxigenic E. coli 61 inhibit replication 61 viral subtypes 61 hepatitis C virus 61 generation NNRTI 61 posterior uveitis 61 nosocomial pneumonia 61 novel VDA molecule 61 relapsing remitting MS RRMS 61 CCR5 tropic 61 HBeAg negative 61 Telbivudine 61 lead Aganocide compound 61 Aflibercept 61 oropharyngeal candidiasis OPC 61 HCV genotype 1 61 Ecallantide 61 posaconazole 61 novel topoisomerase 61 Valopicitabine 61 Gleevec resistant 61 Extensively drug 61 Curaxin CBLC# 61 Alferon LDO 61 human rhinovirus HRV 61 VivaGel TM 61 Chronic hepatitis B 61 CTAP# Capsules 61 Candida species 61 LEP ETU 61 acute GvHD 61 nitazoxanide 61 sodium stibogluconate 61 CCR5 antagonist 61 metastatic neuroendocrine tumors 61 Hepatitis C virus 61 BCG refractory carcinoma 61 hepatitis C viral infection 61 Epstein Barr Virus EBV 61 methicillin resistant S. aureus 61 shingles herpes zoster 61 CMV reactivation 61 nephrotoxicity 61 HCV infection 61 antibody MAb 61 Hemopurifier 61 Alinia 61 HCV 61 bacterium Mycobacterium tuberculosis 61 SNT-MC#/idebenone 61 Salmonella typhi 61 P aeruginosa 61 SinuNase TM 61 precancerous cervical lesions 61 Vidofludimus 61 Actemra tocilizumab 61 MAGE A3 ASCI 61 invasive aspergillosis 61 relapsed MM 61 polymerase inhibitor 60 humanized anti 60 Phase III Pivotal 60 microbiological eradication 60 mRCC 60 bacterium Neisseria meningitidis 60 thymalfasin 60 liposomal formulation 60 orally administered inhibitor 60 methicillin susceptible Staphylococcus aureus 60 pegylated interferon alfa 2a 60 Hepatitis B Virus 60 leukemia AML 60 hepatitis C genotype 60 virus HCV protease inhibitor 60 methylnaltrexone bromide 60 chronic hepatitis B. 60 Sudhir Agrawal D.Phil 60 Helicobacter pylori H. pylori 60 XL# XL# 60 Albuferon TM 60 invasive candidiasis 60 OncoVEX GM CSF 60 catheter occlusion 60 FOLOTYN ® 60 N. gonorrhoeae 60 acetonide FA 60 Lenocta TM 60 chronic HBV 60 metastatic malignant melanoma 60 Hepatitis C Virus HCV 60 T#I mutant 60 PRTX 60 Vicriviroc 60 cirrhosis liver failure 60 cutaneous T 60 soluble tumor necrosis 60 herpes zoster shingles 60 protein tyrosine phosphatase 1B 60 Phase #b/#a clinical 60 alkylating agent 60 Xyfid TM 60 Diabetic Macular Edema 60 investigational monoclonal antibody 60 XL# anticancer compounds 60 mapatumumab 60 Dengue virus 60 herpes zoster virus 60 Bacillus Subtilis 60 mycobacterium tuberculosis 60 Enterobacter cloacae 60 CIMZIA ™ 60 PEGylated anti 60 amikacin 60 SPRYCEL ® 60 polysaccharide polymer 60 nucleotide analogue 60 acyclovir Lauriad R 60 alfa 2a 60 NS5b 60 Hepatitis B virus 60 humanized monoclonal antibody 60 chemokine receptors 60 tenofovir disoproxil fumarate Viread 60 virus HBV 60 ano genital warts 60 inhibitor RG# 60 virus AAV 60 hepatocellular cancer 60 Etravirine 60 synthetic retinoid 60 A1PI 60 non metastatic osteosarcoma 60 Pafuramidine 60 reslizumab 60 MTP inhibitor 60 dasatinib Sprycel 60 Respiratory Syncytial Virus RSV 60 brand ciclesonide HFA 60 Archexin 60 include Healive 60 MEK inhibitor 60 non nucleoside HCV 60 systemically administered 60 nanoviricide 60 FluCide 60 AQ4N 60 vaginal candidiasis 60 overactive bladder syndrome 60 combination antiretroviral therapy 60 invasive fungal infections 60 Vaccine Candidate 60 Candida infection 60 MyVax R 60 CIMZIA TM 60 Genital herpes 60 HCD# [002] 60 severe rotavirus gastroenteritis 60 NEUGENE 60 lomitapide 60 telaprevir VX 59 kidney urologic 59 latent tuberculosis infection 59 nucleoside analog 59 chronic idiopathic thrombocytopenic purpura 59 castrate resistant prostate cancer 59 Alocrest 59 relapsed multiple myeloma 59 HCV NS3 protease 59 Celgosivir 59 zanolimumab 59 ALN PCS 59 HspE7 59 r hGH 59 Haemophilus influenza 59 Enzastaurin 59 OHR/AVR# 59 BARACLUDE R 59 miconazole Lauriad ® 59 non nucleoside inhibitor 59 tigecycline 59 JAK2 enzyme 59 CD3 monoclonal antibody 59 Traficet EN 59 Enterococcus faecium 59 Aclidinium 59 PRT# 59 intravesical instillation 59 Actimmune ® 59 Gemzar ® 59 type 1diabetes 59 Pegasys ® 59 ABSSSI 59 H#N# VLP vaccine 59 treatment naïve genotype 59 lamivudine zidovudine 59 elvucitabine 59 apricitabine 59 sorafenib tablets 59 recombinant adeno associated 59 inhaled liposomal ciprofloxacin 59 hypereosinophilic syndrome 59 metastatic carcinoid 59 relapsed leukemia 59 ALN TTR# 59 Copegus ribavirin 59 RhuDex ® 59 VAPRISOL 59 Fibrillex TM 59 chronic hepatitis C. 59 metastatic GIST 59 Vitrase R 59 voriconazole 59 ISTODAX 59 HCV protease inhibitors 59 cell lymphoma CTCL 59 Vidaza ® 59 PREZISTA r 59 systemic RNAi therapeutic 59 Janus kinase 59 Chlamydia trachomatis 59 ara C 59 Intercell vaccine 59 CCR9 antagonist 59 LymphoStat B TM 59 nucleoside analogues 59 Wafer polifeprosan 59 BARACLUDE ® 59 ketolide antibiotic 59 hypoxia inducible factor 59 Sym# 59 IMA# 59 cidofovir 59 e antigen HBeAg 59 CBLC# 59 HCV protease 59 Chronic Hepatitis B 59 candidemia 59 Seliciclib 59 NRTI resistance 59 Thiovir 59 Candida infections 59 UPLYSO 59 S. aureus bacteremia 59 R#/MEM # 59 Kamada AAT 59 hemorrhagic cystitis 59 discontinued Viread 59 idiopathic thrombocytopenic purpura ITP 59 ATTR CM 59 drug conjugate 59 serogroup B 59 Microplasmin 59 M#V mutation 59 sJIA 59 ChimeriVax JE 59 JAK inhibitor 59 L asparaginase 59 superficial bladder cancer 59 Streptococcus pneumonia 59 tumors GIST 59 pneumococcal serotypes 59 Apaziquone 59 vidofludimus 59 Aurexis 59 b Hib 59 amphotericin B 59 MenB 59 apoptosis inducer 59 antisense drug 59 simplex virus 59 genital herpes infections 59 Xanafide 59 CB2 selective receptor agonist 59 Initiates Phase II 59 Myelofibrosis 59 external genital lesions 59 GW# [003] 59 IAP inhibitor 59 Natalizumab 59 Altastaph 59 Diabetic Neuropathy 59 leukemia CLL 59 carbapenem resistant 59 novel nucleoside analog 59 AGILECT R 59 oral vancomycin 59 Cimzia TM 59 cryptococcosis 59 Durezol 59 immunosuppressed patients 59 Hepatocellular Carcinoma HCC 59 Eculizumab 59 oral proteasome inhibitor 59 HIV coinfected 59 lenalidomide Revlimid R 59 Staphylococcus aureus S. aureus 59 OMNARIS HFA 59 PegIFN RBV 59 Radezolid 59 Ebola Marburg 59 Aeroquin 59 Bavituximab 59 erlotinib Tarceva R 59 docetaxel Taxotere ® 59 Simulect 59 Beta catenin pathway 59 investigational oral hepatitis C 59 corticosteroid dexamethasone 59 trimethoprim sulfamethoxazole 59 virus HCV 59 TRISENOX ® 59 Azedra 59 Ofatumumab 59 recurrent glioblastoma multiforme 59 meropenem 59 systemic fungal infections 59 cIAI 59 nucleoside analogue 59 disease CDAD 59 hemorrhagic fever viruses 59 neuraminidase inhibitor 59 Maribavir 58 intravascular hemolysis 58 delivers fluocinolone acetonide FA 58 nilotinib Tasigna ® 58 INS# [001] 58 humanized monoclonal 58 Solazed TM 58 basal cell carcinoma BCC 58 histone deacetylase HDAC inhibitor 58 anti botulism antibody 58 terlipressin 58 Lixivaptan 58 severe oral mucositis 58 Elvitegravir 58 KSP inhibitor 58 % uracil topical 58 protease inhibitors PIs 58 Bendamustine 58 Dacetuzumab 58 MKC# MT 58 Boceprevir 58 recurrent glioma 58 adenoviral 58 immunomodulators 58 Moxifloxacin 58 nucleoside naive 58 Cryptococcus neoformans 58 primary immunodeficiency PI 58 Daclizumab 58 refractory chronic lymphocytic 58 HCV infections 58 TELCYTA 58 CYP#A# CYP#D# 58 Pralatrexate 58 chronic granulomatous disease 58 pan HDAC inhibitor 58 basiliximab 58 cMET 58 parasite Trypanosoma cruzi 58 Personalized Immunotherapy 58 Civacir 58 imipenem 58 PEGylated 58 ApoB SNALP 58 transcriptase inhibitor NNRTI 58 velafermin 58 ceftazidime 58 postherpetic neuralgia PHN 58 REP# 58 interferon ribavirin 58 grade cervical dysplasia 58 APTIVUS r 58 huC# DM4 58 anterior uveitis 58 gemcitabine cisplatin 58 cilengitide 58 assessing T DM1 58 DAS# [001] 58 OncoVEX 58 Vicinium TM 58 Shigamabs ® 58 Dalbavancin 58 celgosivir 58 CCX# 58 Hemopurifier ® 58 S. suis 58 relapsing multiple sclerosis 58 TELINTRA 58 CIPN 58 S. pyogenes 58 coagulase negative staphylococci 58 non nucleoside 58 cetuximab Erbitux R 58 BRSV 58 Iluvien ® 58 Chronic hepatitis C 58 Catheter Associated 58 phenylketonuria PKU 58 Telintra 58 diabetic neuropathic pain 58 IAP inhibitors 58 staphylococcal infections 58 Hepatitis B virus HBV 58 ImmunoVEX HSV2 58 S. aureus bloodstream infections 58 HGS ETR1 58 Completes Patient Enrollment 58 tyrosine kinase inhibitor TKI 58 calcineurin inhibitor 58 lumiliximab 58 null responder HCV 58 HCV RESPOND 2 58 oral Janus kinase 58 PDX pralatrexate 58 StaphVAX R 58 HeFH 58 Factor VIIa 58 VZV 58 relapsed refractory multiple myeloma 58 drug ISA# 58 Kit CD# positive 58 MDRSP 58 receptor tyrosine kinase inhibitor 58 HBV vaccine 58 Allovectin 7 R 58 Epratuzumab 58 chronic ITP patients 58 CINTREDEKIN BESUDOTOX 58 telbivudine 58 HCV NS5B polymerase 58 cSSSIs 58 Varicella zoster virus 58 trans retinoic acid ATRA 58 Vancomycin resistant 58 intravenous iv 58 HQK 58 relapsing remitting multiple sclerosis 58 suppressive therapy 58 THR beta agonist 58 NNRTI resistant virus 58 echinocandin 58 rindopepimut 58 candidate XP# 58 peripherally acting 58 erlotinib Tarceva ® 58 S. aureus isolates 58 Naive Patients 58 sodium glucose cotransporter 58 JAK2 Inhibitor 58 Nilotinib 58 Staphylococcus aureus MRSA 58 ARIKACE 58 Initiate Clinical Trial 58 targeted radiotherapeutic 58 Chronic Hepatitis C 58 budesonide foam 58 Viread tenofovir disoproxil fumarate 58 AZT zidovudine Retrovir 58 DermaVir Patch 58 NRTI 58 P. falciparum malaria 58 SCH # 58 lexidronam injection 58 imatinib Gleevec ® 58 Talabostat 58 novel histone deacetylase 58 Myelodysplastic Syndrome MDS 58 alpha interferons 58 rilonacept 58 delayed CINV 58 humanized monoclonal antibodies 58 VELCADE melphalan 58 Lymphatic filariasis 58 trastuzumab Herceptin R 58 EGFR HER2 58 oral antiviral 58 B. fragilis 58 Chronic lymphocytic leukemia 58 immunocompetent patients 58 Poly ICLC 58 Phenoptin 58 BCR ABL inhibitors 58 E. faecalis 58 TCAD therapy 58 T#I [002] 58 Phase Ib IIa 58 serotype #A 58 corticosteroid dose 58 equine osteoarthritis 58 ribavirin RBV 58 IRX 2 58 Klebsiella pneumonia 58 small molecule Hedgehog 58 TTR gene 58 diabetic nephropathy 58 JAK2 inhibitor 58 refractory NSCLC 58 Oracea TM 58 Pivotal Phase III 58 Acute Radiation Syndrome ARS 58 interleukin IL -# 58 Irinotecan 58 postoperative inflammation 58 glycopeptide 58 AKT inhibitor 58 Linaclotide 58 INTEGRILIN R 58 doripenem 58 Ozarelix 58 cytomegalovirus infection 58 prokinetic agent 58 Clevudine 58 MOVIPREP R 58 gastro intestinal inflammation 58 piperacillin tazobactam 58 Clostridium difficile associated 58 factor TNF receptor 58 nosocomial pneumonia NP 57 essential thrombocythemia ET 57 lintuzumab SGN 57 pegylated interferon alpha 57 anogenital warts 57 Copegus R 57 Kepivance 57 JAK1 57 radezolid 57 MT#/MEDI-# 57 vancomycin resistant 57 Toxicities 57 HoFH 57 Shigamabs R 57 SIMPONI TM 57 influenza VLP vaccine 57 selective modulator 57 Sustiva efavirenz 57 nutlin 3a 57 Soliris eculizumab 57 Fludase 57 Panzem R 57 Adalimumab 57 neuroendocrine cancers 57 Aviptadil 57 hepatorenal syndrome 57 Ophena TM 57 ORENCIA ® 57 Arcalyst 57 SHPT 57 painful diabetic neuropathy 57 chlamydial 57 Dacogen decitabine 57 initiate Phase 1b 57 Lassa virus 57 investigational integrase inhibitor 57 mertansine 57 dapsone 57 intracranial hemorrhage ICH 57 Plasmodium ovale 57 Alfacell proprietary ribonuclease 57 induced macular edema 57 lupus nephritis 57 post herpetic neuralgia 57 E. coli STEC 57 postoperative ileus 57 ADP receptor antagonist 57 linezolid resistant 57 abacavir lamivudine 57 opioid bowel dysfunction 57 Sezary syndrome 57 Quinamed 57 TLR9 agonist 57 CMV disease 57 recurrent metastatic 57 genital lesions 57 Initiates Enrollment 57 KRAS mutant tumors 57 Streptococcus pyogenes 57 treat chronic sinusitis 57 Adjuvanted 57 Cloretazine 57 metaglidasen 57 alpha folate receptor 57 DEB# 57 sulfamethoxazole 57 pegfilgrastim 57 Chemokine Receptor 57 ATL# [002] 57 refractory chronic myeloid 57 decompensated liver disease 57 TTR amyloidosis 57 EZN 57 Trypanosoma brucei 57 cetuximab Erbitux ® 57 Elotuzumab 57 alefacept 57 ancrod 57 MALT lymphoma 57 bevirimat 57 Streptococcus pneumoniae Haemophilus influenzae 57 proctitis 57 Vascugel 57 fluocinolone acetonide 57 Entereg R 57 vWD 57 Isentress raltegravir 57 NOD SCID mice 57 HGS ETR2 57 Nitazoxanide 57 CRMD# 57 Interferon alfa 57 Begins Dosing 57 pathophysiological effects 57 Diabetic Macular Edema DME 57 Peginterferon 57 LTBI 57 AV HALT 57 KRAS mutant 57 XmAb# 57 PKC# 57 2 methoxyestradiol 57 Initiate Phase 57 Lenocta 57 receptor inhibitor 57 NS5B polymerase 57 Neulasta ® 57 Hsp# Inhibitor 57 Tetanus Toxoids 57 Herpes simplex virus 57 ribavirin therapy 57 C1 INH 57 Veronate 57 Therapeutic Vaccine 57 Aztreonam lysine 57 PEGPH# 57 leukemia ALL 57 esophageal candidiasis 57 M.tb 57 REMINYL ® 57 menadione 57 TKB# 57 pathologic myopia 57 novel antiviral therapeutics 57 Debio 57 rifabutin 57 Panzem R NCD 57 Adefovir 57 adult chronic ITP 57 PROCHYMAL 57 systemic anaplastic large 57 PegIFN 57 nanoviricide drug 57 rusalatide acetate 57 delta isoform 57 Acute myeloid leukemia 57 Herpes zoster 57 CMV seropositive 57 Cx# [002] 57 HuLuc# 57 Achieves Primary Endpoint 57 chickenpox varicella 57 CYT# 57 huN# DM1 57 ATIR 57 Glypromate 57 Vitrasert ® 57 Insegia 57 opioid induced constipation OIC 57 Fx #A 57 CD# monoclonal antibody 57 HBV replication 57 faropenem medoxomil 57 STELARA TM 57 ganciclovir 57 vesicular stomatitis virus 57 busulfan 57 chronic hepatitis C 57 Bronchiectasis 57 HTS assay 57 Golimumab 57 Vacc 4x 57 antiviral efficacy 57 Tasimelteon 57 efalizumab 57 AmBisome 57 Complicated Skin 57 Behcet uveitis 57 SEBIVO 57 Phase IIb Trial 57 BCG refractory 57 Dapagliflozin 57 Pradefovir 57 Rilonacept 57 Peg IFN 57 visceral leishmaniasis VL 57 Atripla combines 57 sunitinib Sutent ® 57 personalized cellular immunotherapy 57 ALN RSV# 57 peginterferon 57 TORISEL 57 oral rivaroxaban 57 adefovir dipivoxil 57 INCB# [001] 57 arsenic trioxide injection 57 PTP 1B 57 Valortim ® 57 immunomodulator 57 Ceflatonin R 57 Cervista HPV HR 57 phase IIb clinical 57 AAG geldanamycin analog 57 infectious diseases autoimmune diseases 57 TNF alpha antagonist 57 induces antibodies 57 hematologic disorders 57 NNRTIs 57 visilizumab 57 MET amplification 57 HCV polymerase inhibitor 57 sapropterin dihydrochloride 57 ankylosing spondylitis AS 57 Glufosfamide 57 EGFR TKI 57 human African trypanosomiasis 57 HPV-#/# 57 VitiGam 57 selective immunoproteasome inhibitor 57 cannabinor 57 K ras mutations 57 diphtheria whooping cough tetanus 57 AzaSite Plus 57 bacterial vaginosis BV 57 Peginterferon alfa 2b 57 tafamidis 57 transthyretin TTR mediated amyloidosis 57 FUSILEV enhances 57 streptococcus bacterium 57 disease Molluscum Contagiosum 57 NS4A 57 GlycoPEGylated hemostasis compounds 57 PI3K/Akt pathway inhibitor 57 VISICOL R 57 Phase 1b clinical 57 Velcade bortezomib 57 Tindamax R 57 formerly LymphoStat B 57 included exfoliative dermatitis 57 ophthalmic diseases 57 APTIVUS 57 Mitoxantrone 57 rFIXFc 57 parainfluenza virus 57 TKM ApoB 57 CD8 responses 57 administered subcutaneously 57 GvHD 57 pegIFN 57 Hepatitis B Hepatitis C 57 Bilive R combined 57 ZFP Therapeutic 57 immuno compromised patients 57 Human Papilloma Virus 57 docetaxel Taxotere R 57 iclaprim 57 XL# XL# XL# XL# 57 Pharmacokinetics PK 57 Androxal TM 57 Neulasta R 57 S.aureus 57 proteasome inhibitor 57 PEG PAL 57 immunomodulatory therapy 57 tuberculin skin testing 57 denileukin diftitox 57 investigational protease inhibitor 57 INVIRASE 57 Elacytarabine 57 Aganocide ® 57 dengue serotype 57 IMiDs 57 P#X# antagonist 57 chlamydial infections 57 adalimumab Humira 57 Resten NG 57 Granulocyte Colony Stimulating Factor 57 FASLODEX 57 Azilect ® 57 acute promyelocytic leukemia 57 HYVISC R 57 cytotoxic effects 57 human C1 inhibitor 57 myelofibrosis polycythemia vera 57 plague bacterium Yersinia 57 phase IIb study 57 Picoplatin 57 recombinant hepatitis B 57 Tarvacin TM 57 ANG# 57 Onalta 57 Voreloxin 57 MVA BN 57 elotuzumab 57 vancomycin resistant Staphylococcus aureus 57 reduce serum phosphate 57 polyneuropathy HIV DSP 57 epithelial tumors 57 telaprevir dosed 57 amprenavir 57 ruxolitinib 57 vinorelbine tartrate 57 Noxafil 57 Zalypsis 57 P. vivax malaria 57 Deferiprone 57 Pseudomonas infections 56 Twinrix 56 T#I mutation 56 Hib disease 56 HGS# 56 coinfection 56 organ transplant rejection 56 topical gel formulation 56 Amplimexon 56 Laquinimod 56 nasal carriage 56 multidrug resistant 56 bexarotene 56 small molecule tyrosine 56 tiapamil 56 Arikace 56 BENLYSTA ® 56 immune modulatory 56 Virologic 56 delafloxacin 56 topically administered 56 CD# CEA 56 Darinaparsin 56 Omalizumab 56 bacteria Neisseria meningitidis 56 intranasal formulation 56 Fludara ® 56 candidates Azedra TM 56 parasitemia 56 DOS# 56 Pazopanib 56 refractory CLL 56 Oxycyte ® 56 pneumococci 56 ATTR PN 56 opioid induced constipation 56 multidrug resistant MDR 56 vapreotide acetate 56 BRAF kinase 56 Acute Bacterial Skin 56 Glioblastoma Multiforme 56 ZOLINZA 56 solithromycin 56 PSMA ADC 56 HCV protease inhibitor 56 Aptivus ® 56 G#DT 56 gastrointestinal disorders ATI 56 Sapacitabine 56 Hepatitis C Virus 56 Elagolix 56 fibrotic disease 56 HER2 overexpression 56 Phase #/#a 56 herpesviruses 56 oral JAK#/JAK# inhibitor 56 nucleoside reverse transcriptase inhibitor 56 HuMax CD4 56 efavirenz emtricitabine 56 dacarbazine 56 H pylori 56 nonvaccine serotypes 56 Tofacitinib 56 PAOD 56 lesinurad 56 ARIKACE ™ 56 tumor xenograft models 56 VivaGel ™ 56 Virus HIV 56 HBeAg positive patients 56 ritonavir boosting 56 viral conjunctivitis 56 S. aureus colonization 56 NovaBay Aganocide compounds 56 coagulation abnormalities 56 entecavir 56 protease inhibitor PI 56 Azixa 56 EV# vaccine 56 systemic lupus erythematosus psoriasis 56 abacavir Ziagen 56 S. pneumoniae 56 DENV 56 systemic absorption 56 CFTR corrector 56 Pegylated Interferon 56 Advanced Melanoma 56 mTOR mammalian target 56 Human papillomavirus HPV 56 ILUVIEN ® 56 VGV 1 56 Tarvacin 56 smoldering multiple myeloma 56 lopinavir ritonavir Kaletra 56 next generation URAT1 56 ZADAXIN ® 56 transcriptase inhibitor 56 influenzae 56 Annamycin 56 dermal patch 56 REMUNE R 56 ADPKD 56 VFEND 56 Copegus ® 56 S aureus 56 superantigens 56 peginterferon alfa 2a 56 CYP#A# substrate 56 vivax 56 telomerase therapeutic 56 injectable formulation 56 Dengue Hemorrhagic Fever 56 gemcitabine carboplatin 56 rALLy clinical trial 56 Rheumatoid arthritis RA 56 vWF 56 Amgen Neulasta ® 56 Salmonella Typhi